Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus

American Journal of Obstetrics and Gynecology

Volumn 190, Issue 5, 2004, Pages 1241-1248

  Massad, L Stewart ^a   Silverberg, Michael J ^b   Springer, Gayle ^b   Minkoff, Howard ^c   Hessol, Nancy ^d   Palefsky, Joel M ^d   Strickler, Howard D ^e   Levine, Alexandra M ^f   Sacks, Henry S ^g   Moxley, Michael ^h   Watts, D Heather ⁱ  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^h GEORGETOWN UNIVERSITY HOSPITAL   (United States)

ⁱ EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Genital warts; Human immunodeficiency virus; Human papillomavirus; Vulvar cancer; Vulvar neoplasia

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CD4 ANTIGEN; VIRUS DNA; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE DISTRIBUTION; ARTICLE; BIOPSY; CHILD; CLINICAL EXAMINATION; CLINICAL TRIAL; COHORT ANALYSIS; CONDYLOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA FINGERPRINTING; DRUG EFFECT; EPITHELIUM; HEALTH HAZARD; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PAPANICOLAOU TEST; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RNA ANALYSIS; SEROLOGY; SMOKING; VULVA TUMOR; WART VIRUS;

EID: 2542436684     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2003.12.037     Document Type: Article

References (16)

1. Friis S, Kjaer SK, Frisch M, Mellemkjaer L, Olsen JH. Cervical intraepithelial neoplasia, anogenital cancer, and other cancer types in women after hospitalization for condylomata acuminata. J Infect Dis 1997;175:743-8.
2. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999;91:226-36.
3. Conley LJ, Ellerbrock TV, Bush TJ, Chiasson MA, Sawo D, Wright TC. HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study. Lancet 2002;359:108-13.
4. Chirgwin KD, Feldman J, Augenbraun M, Landesman S, Minkoff H. Incidence of venereal warts in human immunodeficiency virus-infected and uninfected women. J Infect Dis 1995;172:235-8.
5. Ghys PD, Diallo MO, Ettiegne-Traore V, Yeboue KM, Gnaore E, Lorougnon F, et al. Genital ulcers associated with human immunodeficiency virus-related immunosuppression in female sex workers in Abidjan, Ivory Coast. J Infect Dis 1995;172:1371-4.
6. Minkoff HL, Eisenberger-Matityahu D, Feldman J, Burk R, Clarke L. Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus. Am J Obstet Gynecol 1999;180:824-36.
7. Greenblatt RM, Bacchetti P, Barkan S, Augenbraun M, Silver S, Delapenha R, et al. Lower genital tract infections among HIV-infected and high-risk uninfected women: findings of the Women's Interagency HIV Study (WIHS). Sex Transm Dis 1999;26:143-51.
8. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60.
9. Barkan SE, Melnick SL, Martin-Preston S, Weber K, Kalish LA, Miotti P, et al. The Women's Interagency HIV Study. Epidemiology 1998;9:117-25.
10. Centers for Disease Control Prevention. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Morb Mort Wkly Rep 1998;47(RR-5):1-82 Updated July 14, 2003. Available at http://aidsinfo.nih.gov/ guidelines/ adult/AA_071403.pdf.
11. Palefsky JM, Holly EA, Ralston ML, Da Costa M, Bonner H, Jay N, et al. Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J AIDS 2001;28:422-8.
12. van Benthem BHB, Prins M, Larsen C, Delmas MC, Brunet JB, van den Hoek A. Sexually transmitted infections in European HIV-infected women: Incidence in relation to time from infection. AIDS 2000;14:595-603.
13. Wilson TE, Massad LS, Riester KA, Barkan S, Richardson J, Young M, et al. Sexual, contraceptive, and drug use behaviors of women with HIV and those at high risk for infection: results from the Women's Interagency HIV Study. AIDS 1999;13:591-8.
14. de Panfilis G, Melzani G, Mori G, Ghidini A, Graifemberghi S. Relapses after treatment of external genital warts are more frequent in HIV-positive patients than in HIV-negative controls. Sex Transm Dis 2002;29:121-5.
15. Silverberg MJ, Ahdieh L, Munoz A, Anastos K, Burk RD, Cu-Cvin S, et al. The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection on genital warts. Sex Transm Dis 2002;29:427-35.
16. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000;92:1500-10.